Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2692 participants.
Also called NCT02923726
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose basic science
- Phase
- Not applicable
- Enrolled
- 2,692 participants
- Sponsor
- Registry
-
NCT02923726
-
- Other papers using this trial's data
- Assessment of Antitachycardia Pacing in Primary Prevention Patients: The APPRAISE ATP Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Canada, Italy, Japan, South Korea, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02923726. Randomized; single masking; primary purpose basic science. Start 2016-09-30 (actual); primary completion 2023-07-06 (actual). Results posted on 2024-10-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
- Acronym
- APPRAISE ATP
- Condition
- Sudden Cardiac Death
- Intervention (Device)
- Arm 1 (ATP+Shock)
- Intervention (Device)
- Arm 2 (shock only)
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02923726- Content hash
7196f0e0b46760633c096a8c3c77da03953abdc8a6675ce102f5ecf21c5f2f65